Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
JNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
GermanyTulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
BelgiumBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
AustriaA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
BelgiumComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
BulgariaA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
AustriaA study to evaluate the safety of REGN7041 in adults with active noninfectious uveitis affecting the back of the eye.
FranceEvaluation of safety and efficacy of 19CP02 combined with cyclophosphamide and fludarabine phosphate in adults with treatment‑refractory active systemic lupus erythematosus
BelgiumEvaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion
BulgariaSafety, Tolerability and Antiretroviral Activity of a Single Oral Dose of MK-8527 in ART‑Naïve Adults with HIV‑1
RomaniaEfficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial
BulgariaA study to examine how the body processes and removes DC-806 in healthy male volunteers
The NetherlandsThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
